Steven Cohen’s iShares Biotechnology ETF IBB Stock Holding History

Steven Cohen’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-15,000	Closed	-$1.69M	–	778
2015 Q4	$1.69M	Buy	+15,000	New	+$1.63M	0.01%	569

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Steven Cohen's IBB Position: Q1 2016 in Review

Steven Cohen sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 15,000 shares — an estimated $1.69M sold.

Steven Cohen first reported a position in IBB in Q4 2015 and held it in 1 quarter. The position peaked at $1.69M in Q4 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

Steven Cohen reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
Steven Cohen sold 15,000 iShares Biotechnology ETF shares in Q1 2016, an estimated $1.69M.
Steven Cohen first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 1 quarter.
Steven Cohen's iShares Biotechnology ETF position peaked at $1.69M in Q4 2015.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Point72 Asset Management's 13F filing for Q1 2016, filed 16 May 2016.